Showing results (251-260 of 376) with videos related to
Sort By:
Pageof 38
Journal of Oncology Practice|January 24, 2019
Decreasing Inappropriate Use of Rasburicase to Promote Cost-Effective CareKomal K Patel, Timothy J Brown, Arjun Gupta, et al.JCO Clinical Cancer Informatics|January 18, 2019
Feasibility of Wearable Physical Activity Monitors in Patients With CancerArjun Gupta, Tyler Stewart, Nizar Bhulani, et al.Spine Deformity|December 2, 2025
State of the art review: enhanced recovery after surgery (eras) protocols in adolescent idiopathic scoliosisMatthew J Weintraub, Arjun Gupta, Neil K Kaushal, et al.Current Problems in Cancer|October 20, 2023
Creating a culture for change: Lessons from behavioral economics and complexity science to increase serious illness conversations for patients with cancerRamy Sedhom, Jasmine Tomita-Barber, Christopher R Manz, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 9, 2017
Race- and Sex-Based Disparities in the Therapy and Outcomes of Squamous Cell Carcinoma of the AnusNivedita Arora, Arjun Gupta, Hong Zhu, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 15, 2013
The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based studyNicole M Gentile, Sahil Khanna, Edward V Loftus, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 1, 2021
Microscopic Colitis and Risk of Colon Adenomas: A Multicenter Retrospective Cohort StudyAmrit K Kamboj, Haley M Zylberberg, Conor M Lane, et al.Therapeutic Advances in Gastroenterology|November 13, 2025
Prevention of recurrent Clostridioides difficile infection by fecal microbiota, live-jslm (REBYOTA®) administered via colonoscopy: 6-month data from the single-arm phase IIIb CDI-SCOPE trialSahil Khanna, David Yoho, Daniel Van Handel, et al.Therapeutic Advances in Gastroenterology|May 5, 2025
Safety and effectiveness of fecal microbiota, live-jslm (REBYOTA®) administered by colonoscopy for prevention of recurrent Clostridioides difficile infection: 8-week results from CDI-SCOPE, a single-arm, phase IIIb trialSahil Khanna, David Yoho, Daniel Van Handel, et al.Journal of Geriatric Oncology|October 30, 2020
Changes in the place of death for older adults with cancer: Reason to celebrate or a risk for unintended disparities?Ramy Sedhom, Pei-Lun Kuo, Arjun Gupta, et al.Pageof 38